ARCHIVES

Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent

This article is from The Cancer Letter archive.

Vol. 08 No. 02 | January 8, 1982

Download PDF Visit The Full Archive

Related Articles

Duke wins Avon-NCI funding.

October 31, 2003

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

April 21, 1989

Avastin Improves PFS Compared To Chemo Alone

January 29, 2010

Fisher To Direct Wilmot CC

October 5, 2001

HHS Draft of Bill Reauthorizing NIH Specifically Kills Bypass Budget, Would End National Cancer Act of 1971

March 29, 1985

In Brief: Panel to Meet June 9 In Boston; Iverson Takes Position At U. Colo.’Namovicz Leaving NHLBI

May 23, 1986